Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

ORGS Relative to the S&P 500

ORGS Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Orgenesis Inc. (OTCMKT:ORGS) seasonal charts above shows that a Buy Date of January 11 and a Sell Date of March 31 has resulted in a geometric average return of 69.94% above the benchmark rate of the S&P 500 Total Return Index over the past 14 years. This seasonal timeframe has shown positive results compared to the benchmark in 11 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 14 years by an average of 73.94% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company’s business includes two reporting segments: Octomera and Therapies.

To download ORGS seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: ORGS